Healthy Clinical Trial
Official title:
Remote Study of an Electronic Means to Characterize Bowel Movements in Adult Populations
Verified date | April 2022 |
Source | HealthMode Inc. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
A remote study to find out if a mobile phone application (HealthMode Stool) can serve as a useful tool to track and characterize daily bowel movements. The application provides participants with a single place to record their bowel movements either as a part of their general health self-monitoring, or because they may be dealing with a bowel movement condition. The minimal study duration is 1 month, and participants can continue using the application up to 2 years.
Status | Active, not recruiting |
Enrollment | 843 |
Est. completion date | July 2022 |
Est. primary completion date | July 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Females and males over 18 years old - Willing to use their own/personal mobile phone (iPhone 6 or higher, running iOS 11 or higher) for participation - Willing to share demographic data with the sponsor of the study - Willing to follow app use instructions during the course of the study - Willing to log the bowel movement events on a daily basis with manual input of additional characteristics - Willing to complete survey instruments as described in study procedures - Willing to provide electronic informed consent - Able to read and understand the english language well enough to complete electronic informed consent Exclusion Criteria: - New to HealthMode Stool application: - No additional exclusion criteria. OR - Current HealthMode Stool User: - Is an active participant in any other study using HealthMode Stool app in its protocol. |
Country | Name | City | State |
---|---|---|---|
United States | Virtual Facility | Bronx | New York |
Lead Sponsor | Collaborator |
---|---|
HealthMode Inc. |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Sensitivity and specificity of models for automatic determination of bowel movement characteristics | Receiver Operating Characteristic of created mathematical models | 28 days | |
Primary | Dataset completeness | Aiming for 90% in two dataset completeness aspects: bowel movement entry days and bowel movement characteristics completeness. | 28 days | |
Secondary | Daily bowel movement characteristics and fluctuation | Measured as category frequency and fluctuations in Bristol Stool Scale items | 28 days | |
Secondary | Daily bowel movement characteristics and fluctuation | Measured as changes in Gastro-intestinal Symptom Rating Scale score. The score ranges from 15 to 105, lower score indicating a better outcome | 28 days | |
Secondary | Daily bowel movement characteristics and fluctuation | Measured as changes in Visceral Sensitivity Index score. The score ranges from 15 to 90, lower score indicating a worse outcome | 28 days | |
Secondary | Usability of the application | Level of usability of the solution by patients by means of a Standard Usability Questionnaire score. The score ranges from 10 to 50, higher score indicating a better usability. | 28 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |